| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Stockholm Gerontology Research Center and Division of Geriatric Medicine (Drs. Wang, Wahlin, Basun, Fastbom, Winblad, and Fratiglioni), NEUROTEC, Karolinska Institutet, Stockholm; and Astra Zeneca (Dr. Basun), Clinical Science, R & D Södertälje, Sweden.
Address correspondence and reprint requests to Dr. Hui-Xin Wang, Stockholm Gerontology Research Center, Box 6401, S-113 82 Stockholm, Sweden; e-mail: Huixin.wang{at}phs.ki.se
OBJECTIVE: To explore the associations of low serum levels of vitamin B12 and folate with AD occurrence.
METHODS: A population-based longitudinal study in Sweden, the Kungsholmen Project. A random sample of 370 nondemented persons, aged 75 years and older and not treated with B12 and folate, was followed for 3 years to detect incident AD cases. Two cut-off points were used to define low levels of vitamin B12 (
150 and 250 pmol/L) and folate (10 and 12 nmol/L), and all analyses were performed using both definitions. AD and other types of dementia were diagnosed by specialists according to DSM-III-R criteria.
RESULTS: When using B12 150pmol/L and folate 10 nmol/L to define low levels, compared with people with normal levels of both vitamins, subjects with low levels of B12 or folate had twice higher risks of developing AD (relative risk [RR] = 2.1, 95% CI = 1.2 to 3.5). These associations were even stronger in subjects with good baseline cognition (RR = 3.1, 95% CI = 1.1 to 8.4). Similar relative risks of AD were found in subjects with low levels of B12 or folate and among those with both vitamins at low levels. A comparable pattern was detected when low vitamin levels were defined as B12 250 pmol/L and folate 12 nmol/L.
CONCLUSIONS: This study suggests that vitamin B12 and folate may be involved in the development of AD. A clear association was detected only when both vitamins were taken into account, especially among the cognitively intact subjects. No interaction was found between the two vitamins. Monitoring serum B12 and folate concentration in the elderly may be relevant for prevention of AD.
This article has been cited by other articles:
|
|
 |
|
  N. Coley, S. Andrieu, V. Gardette, S. Gillette-Guyonnet, C. Sanz, B. Vellas, and A. Grand Dementia Prevention: Methodological Explanations for Inconsistent Results Epidemiol. Rev., November 1, 2008; 30(1): 35 - 66. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. de Lau, H. Refsum, A D. Smith, C. Johnston, and M. M. Breteler Plasma folate concentration and cognitive performance: Rotterdam Scan Study Am. J. Clinical Nutrition, September 1, 2007; 86(3): 728 - 734. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Raman, A. Tatsioni, M. Chung, I. H. Rosenberg, J. Lau, A. H. Lichtenstein, and E. M. Balk Heterogeneity and Lack of Good Quality Studies Limit Association Between Folate, Vitamins B-6 and B-12, and Cognitive Function J. Nutr., July 1, 2007; 137(7): 1789 - 1794. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. Balk, G. Raman, A. Tatsioni, M. Chung, J. Lau, and I. H. Rosenberg Vitamin B6, B12, and Folic Acid Supplementation and Cognitive Function: A Systematic Review of Randomized Trials Arch Intern Med, January 8, 2007; 167(1): 21 - 30. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Luchsinger, M.-X. Tang, J. Miller, R. Green, and R. Mayeux Relation of Higher Folate Intake to Lower Risk of Alzheimer Disease in the Elderly Arch Neurol, January 1, 2007; 64(1): 86 - 92. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Thomas and M. Fenech A review of genome mutation and Alzheimer's disease Mutagenesis, January 1, 2007; 22(1): 15 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Feng, T.-P. Ng, L. Chuah, M. Niti, and E.-H. Kua Homocysteine, folate, and vitamin B-12 and cognitive performance in older Chinese adults: findings from the Singapore Longitudinal Ageing Study Am. J. Clinical Nutrition, December 1, 2006; 84(6): 1506 - 1512. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Tettamanti, M. T. Garri, A. Nobili, E. Riva, and U. Lucca Low Folate and the Risk of Cognitive and Functional Deficits in the Very Old: The Monzino 80-plus Study J. Am. Coll. Nutr., December 1, 2006; 25(6): 502 - 508. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Annerbo, L.-O. Wahlund, and J. Lokk The Significance of Thyroid-Stimulating Hormone and Homocysteine in the Development of Alzheimer's Disease in Mild Cognitive Impairment: A 6-Year Follow-up Study American Journal of Alzheimer's Disease and Other Dementias, May 1, 2006; 21(3): 182 - 188. [Abstract] [PDF]
|
|
|
|
 |
|
 C. M. Pfeiffer, Z. Fazili, L. McCoy, M. Zhang, and E. W. Gunter Determination of Folate Vitamers in Human Serum by Stable-Isotope-Dilution Tandem Mass Spectrometry and Comparison with Radioassay and Microbiologic Assay Clin. Chem., February 1, 2004; 50(2): 423 - 432. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Refsum, A. D. Smith, P. M. Ueland, E. Nexo, R. Clarke, J. McPartlin, C. Johnston, F. Engbaek, J. Schneede, C. McPartlin, et al. Facts and Recommendations about Total Homocysteine Determinations: An Expert Opinion Clin. Chem., January 1, 2004; 50(1): 3 - 32. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. C. Rampersaud, G. P.A. Kauwell, and L. B. Bailey Folate: A Key to Optimizing Health and Reducing Disease Risk in the Elderly J. Am. Coll. Nutr., February 1, 2003; 22(1): 1 - 8. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Bottiglieri S-Adenosyl-L-methionine (SAMe): from the bench to the bedside--molecular basis of a pleiotrophic molecule Am. J. Clinical Nutrition, November 1, 2002; 76 (5): 1151S - 1157S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Squitti, D. Lupoi, P. Pasqualetti, G. Dal Forno, F. Vernieri, P. Chiovenda, L. Rossi, M. Cortesi, E. Cassetta, and P. M. Rossini Elevation of serum copper levels in Alzheimer's disease Neurology, October 22, 2002; 59(8): 1153 - 1161. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E H Reynolds Folic acid, ageing, depression, and dementia BMJ, June 22, 2002; 324(7352): 1512 - 1515. [Full Text] [PDF]
|
|
|
|
|
|
A. McCaddon, B. Regland, P. Hudson, and G. Davies Functional vitamin B12 deficiency and Alzheimer disease Neurology, May 14, 2002; 58(9): 1395 - 1399. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A D. Smith Homocysteine, B vitamins, and cognitive deficit in the elderly Am. J. Clinical Nutrition, May 1, 2002; 75(5): 785 - 786. [Full Text] [PDF]
|
|
|
|
 |
|
 E H Reynolds Benefits and risks of folic acid to the nervous system J. Neurol. Neurosurg. Psychiatry, May 1, 2002; 72(5): 567 - 571. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Seshadri, A. Beiser, J. Selhub, P. F. Jacques, I. H. Rosenberg, R. B. D'Agostino, P. W.F. Wilson, and P. A. Wolf Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease N. Engl. J. Med., February 14, 2002; 346(7): 476 - 483. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. R. M. Rieder, D. Fricke, H. X. Wang, A. Wahlin, H. Basun, J. Fastbom, B. Winblad, and L. Fratiglioni Vitamin B12 and folate in relation to the development of Alzheimer's disease Neurology, November 13, 2001; 57(9): 1742 - 1743. [Full Text] [PDF]
|
|
Read all Correspondence
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
